FABP4 and FABP2 have recently been reported to have a significant association with cancer progression in patients with colorectal cancer [16] and several studies demonstrate that obesity and high fat intake are risk factors in colorectal cancer [13,25-28]. Here, FABP2 is linked to obesity due to melanocortin 4 receptor deficiency.